Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308

NCT03616392 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type II

Interventions

DRUG: D308, CKD-501

Sponsor

Chong Kun Dang Pharmaceutical